Amplification of EMSY, a novel oncogene on 11q13, in high grade ovarian surface epithelial carcinomas
- 28 February 2006
- journal article
- Published by Elsevier in Gynecologic Oncology
- Vol. 100 (2) , 264-270
- https://doi.org/10.1016/j.ygyno.2005.08.026
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Hallmarks of 'BRCAness' in sporadic cancersNature Reviews Cancer, 2004
- Amplification of the BRCA2 Pathway Gene EMSY in Sporadic Breast Cancer Is Related to Negative OutcomeClinical Cancer Research, 2004
- A Novel BRCA2-Binding Protein and Breast and Ovarian TumorigenesisNew England Journal of Medicine, 2004
- BRCA-related ovarian carcinomaCancer, 2003
- Prevalence and Penetrance of Germline BRCA1 and BRCA2 Mutations in a Population Series of 649 Women with Ovarian CancerAmerican Journal of Human Genetics, 2001
- EMS1 gene expression in primary breast cancer: relationship to cyclin D1 and oestrogen receptor expression and patient survivalOncogene, 1998
- Detailed map of a region commonly amplified at 11q13→q14 in human breast carcinomaCytogenetic and Genome Research, 1997
- 11q13 Amplification in local recurrence of human primary breast cancerGenes, Chromosomes and Cancer, 1995
- Patterns of dna amplification at band q13 of chromosome 11 in human breast cancerGenes, Chromosomes and Cancer, 1994
- Gene amplification on chromosome band 11q13 and oestrogen receptor status in breast cancerEuropean Journal of Cancer and Clinical Oncology, 1990